The CXC-chemokine receptor-4 (CXCR4) pathway plays a role in cancer cell homing and metastasis, representing a potential target for cancer therapy, i.e., CXCR4 activates mTOR and the Bruton tyrosine kinase [28]. Here, BTK is linked to cancer.